by
Lisa Chamoff, Contributing Reporter | December 18, 2017
Kay Eron, general manager for analytics industry solutions for Intel, said the company is partnering with public and private cloud service providers to enable platforms optimized for storage-heavy workloads, particularly for genomics research and in medical imaging in emerging markets.
In China, lower usage of PACS and VNAs has led to many facilities jumping right into the cloud for their storage needs, instead of investing in infrastructure, Eron said.
The third key prediction for 2018 is that big tech companies will see a high reward for their investments, and an FDA program designed to fast track digital therapeutics will provide significant impetus for nontraditional companies, such as Google, Apple, Samsung and Fitbit, to enter the medical arena.
Microsoft is not only trying to build the underlying cloud infrastructure, but also interlaced micro-services across the cloud, explained Neil Jordan, the general manager for the worldwide health industry at Microsoft. For example, the company recently released a new set of services to enable a much faster computing and management of genomic data.
“Rather than go directly into trying to deliver genomic analysis ourselves, we decided the best way to do it was to provide that through partners,” Jordan said. “At the same time, also trying to deliver direct first party solutions in a software-as-a-service model. I think it’s making a balance of both that first-party and third-party approach that will help big tech companies both provide the value that they need to provide … but also provide the scale and the variability and flexibility that is going to be needed for all of the different ways that health care is delivered across the globe.”
As for dire predictions, Behera said despite increased investment in security, cyberattacks on the health care industry are expected to double in 2018.
“Given the increasing penetration of connected health devices, we anticipate that cyberattacks and malware threats will result in a major, multimillion-dollar risk for litigation,” Behera said.
Back to HCB News
